Targeting the lncRNA DUXAP8/miR-29a/<i>PIK3CA</i> Network Restores Doxorubicin Chemosensitivity <i>via</i> PI3K-AKT-mTOR Signaling and Synergizes With Inotuzumab Ozogamicin in Chemotherapy-Resistant B-Cell Acute Lymphoblastic Leukemia.

Front Oncol · 2022 · PMC8924619 · PMID 35311115

Europe PMC DOI

hedged sentence

0.0640

closest p · 1.3× alpha

0.0640

boldest claim

The sentences

showed a trendp = 0.064so close (0.05 < p ≤ 0.1)

It was notable that by comparison, S-ALL patients showed a trend of lower WBC ( p = 0.064) and CD19 percentage ( p = 0.065) compared to R-ALL patients but lacked statistical significance.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.